Treatment of Hypereosinophilic Syndrome with Cutaneous Involvement with the JAK Inhibitors Tofacitinib and Ruxolitinib

Brett King*, Alfred Ian Lee, Jaehyuk Choi

*Corresponding author for this work

Research output: Contribution to journalArticle

19 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)951-954
Number of pages4
JournalJournal of Investigative Dermatology
Volume137
Issue number4
DOIs
StatePublished - Apr 1 2017

Fingerprint

Piperidines
Pyrazoles
Pyrimidines
Pyrroles
INCB018424
tofacitinib

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Dermatology
  • Cell Biology

Cite this

@article{16eb217b649b40d395604f53c03f69eb,
title = "Treatment of Hypereosinophilic Syndrome with Cutaneous Involvement with the JAK Inhibitors Tofacitinib and Ruxolitinib",
author = "Brett King and Lee, {Alfred Ian} and Jaehyuk Choi",
year = "2017",
month = "4",
day = "1",
doi = "10.1016/j.jid.2016.10.044",
language = "English (US)",
volume = "137",
pages = "951--954",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "Nature Publishing Group",
number = "4",

}

Treatment of Hypereosinophilic Syndrome with Cutaneous Involvement with the JAK Inhibitors Tofacitinib and Ruxolitinib. / King, Brett; Lee, Alfred Ian; Choi, Jaehyuk.

In: Journal of Investigative Dermatology, Vol. 137, No. 4, 01.04.2017, p. 951-954.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Treatment of Hypereosinophilic Syndrome with Cutaneous Involvement with the JAK Inhibitors Tofacitinib and Ruxolitinib

AU - King, Brett

AU - Lee, Alfred Ian

AU - Choi, Jaehyuk

PY - 2017/4/1

Y1 - 2017/4/1

UR - http://www.scopus.com/inward/record.url?scp=85015956860&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015956860&partnerID=8YFLogxK

U2 - 10.1016/j.jid.2016.10.044

DO - 10.1016/j.jid.2016.10.044

M3 - Article

C2 - 27887955

AN - SCOPUS:85015956860

VL - 137

SP - 951

EP - 954

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

SN - 0022-202X

IS - 4

ER -